Báo cáo y học: "A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin® for treatment of osteoarthritis of the knee" potx

... properties by inhibiting the 5-lipoxygenase enzyme. A 90-day, double- blind, randomized, placebo- controlled study was conducted to evaluate the efficacy and safety of 5-Loxin ® in the treatment of osteoarthritis ... not for citation purposes) Vol 10 No 4 Research article A double blind, randomized, placebo controlled study of the efficacy a...

Ngày tải lên: 09/08/2014, 10:23

... the isolation of the gene locus, full-length cDNA and the functional analysis of the corresponding protein of T. gondii that displays strong similarities with the P. falci- parum, P. yoelii and ... tachyzoites. The tachyzoites differentiate into encysted bradyzoites in response to the immune system attack during disease progression. They will remain in the brain and...

Ngày tải lên: 08/03/2014, 22:20

... Raychaudhuri SP. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin ® for treatment of osteoarthritis of the knee. Arthritis Res. Ther. 2008; 10(4): ... in the present clinical study we sought to evaluate the comparative efficacy and tolerability of 5-L o xin ® and Aflapin ® in the treatment of...

Ngày tải lên: 25/10/2012, 11:40

... under any conditions and attempts to purify the kinase by gel elution gave a very low yield and the eluted protein was highly labile. The 40-kDa protein is phosphorylated by PsCCaMK and binds ... pathway, these second messengers and/ or other accessory protein(s) affected by them modulate the activity of the transcription factors, which regulate the expression of specifi...

Ngày tải lên: 18/03/2014, 01:20

... randomized, double- blind, placebo- controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia. J Psychiatr ... than the prestudy medication. Safety and tolerability Of the 245 subjects who were included in the safety sample, 163 (66.5%) experienced an AE...

Ngày tải lên: 09/08/2014, 01:21

... significantly improved by tropisetron trial. Conclusions: This first randomised, double- blind, placebo- controlled trial supports the safety and efficacy of adjunctive tropisetron for treatment of cognitive ... by the Department of Pharmacy of Chiba University Hospital. Clinical variables and cognition The Positive and Negative Syndrome Scale (PANSS) was us...

Ngày tải lên: 08/08/2014, 23:21

... at the Division of Radiotherapy and Medical Oncology, Ospedale Civile in Pordenone, for 6 years and at the Division of Medical Oncology, Centro di Riferimento Oncologico, in Aviano, for 13 years. ... mg/m 2 for 5 days followed by Cisplatin at 100 mg/m 2 on the 6 th or 7 th day every 28 days; the other 61 received no further treatment (nihil group). Results. Six...

Ngày tải lên: 03/11/2012, 09:57

... phase II randomized, double- blind, placebo- controlled trial of 30 µg IFN-β-1a by weekly self-injection for 24 weeks. The primary outcome of the study was safety. Secondary outcomes included the proportion ... information. The primary outcome of the study was safety. IFN-β-1a was generally well tolerated by these RA patients. We did not see any serious safet...

Ngày tải lên: 09/08/2014, 01:23

... compute the average FWHM and amplitude for the region by taking the mean of the forward and reverse val- ues. We then take the top quartile of the enriched regions according to average amplitude and ... estimates a* and m* are of the amplitudes and positions of the binding sites, and the estimate N* is of the number of the components in the en...

Ngày tải lên: 09/08/2014, 20:21

... emergency vehi- cle with light -and- siren response for the study purpose only. This study of documentation quality was part of a cross-sectional MVA study evaluating whether patient injury pattern and ... analysis, and the drafting, revising, and final approval of the manuscript. SS was involved in the study conception and design, data analysis, and in the...

Ngày tải lên: 25/10/2012, 09:56